Medtronic’s Record Mazor Sales Temper Overall Declines

Medtronic's logo

Medtronic reported FY 3Q21 orthopedic revenue of $740.7 million, -4.5% vs. FY 3Q20. While the timing of Medtronic’s fiscal calendar can sometimes mask market conditions, lagging sales from COVID’s second wave continued to hamper the company through mid-February. Leadership expects sequential improvement through March and April.


document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Mike Evers is a Senior Market Analyst and writer with over 15 years of experience in the medical industry, spanning cardiac rhythm management, ER coding and billing, and orthopedics. He joined ORTHOWORLD in 2018, where he provides market analysis and editorial coverage.

Contact Us